OLEMA PHARMACEUTICALS INC (OLMA)
US68062P1066 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -96.66M | -104.79M | -71.10M | -22.12M | -4.32M | |||
| Depreciation Amortization | 377.00K | 360.00K | 160.00K | 10.00K | 10.00K | |||
| Change In Working Capital | -589.00K | 3.02M | 2.83M | -1.51M | 1.23M | |||
| Other non cash items | 13.14M | 19.34M | 17.41M | 3.75M | 0.00 | |||
| OPERATING CASH FLOW | -83.73M | -82.07M | -50.69M | -19.87M | -3.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -360.00K | -1.58M | -60.00K | 0.00 | |||
| Other Investing Activity | -4.85M | 91.84M | -273.86M | N/A | N/A | |||
| INVESTING CASH FLOW | -4.85M | 91.48M | -275.44M | -60.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 3.09M | 0.00 | |||
| Stock Issued/Repurchased | 3.68M | 480.00K | 1.39M | 355.32M | 0.00 | |||
| Other Financing Activity | 129.74M | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 133.41M | 480.00K | 1.39M | 358.40M | 0.00 | |||
| CHANGE IN CASH | 44.84M | 9.89M | -324.74M | 338.47M | -3.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -83.73M | -82.07M | -50.69M | -19.87M | -3.08M | |||
| Capital Expenditure | 0.00 | -360.00K | -1.58M | -60.00K | 0.00 | |||
| FREE CASH FLOW | -83.73M | -82.43M | -52.27M | -19.93M | -3.08M | |||
All data in USD